PRPS2 and non-small cell lung carcinoma: For instance, the enriched PRPS2 in the exosomes of non-small-cell lung carcinoma (NSCLC) cells mediates the polarization of M2 macrophages to promote the cisplatin resistance of non-small-cell lung cancer (NSCLC) cells [16].